Alkem Laboratories

Please find Attached herewith Intimation for Incorporation of Wholly owned subsidiary of the Company.

13 Apr, 2026 | 03:38pm • Source: BSE

Please find attached herewith Press release- Alkem Launches A to Z Daily, an everyday multivitamin supplement for body and mind.

07 Apr, 2026 | 03:30pm • Source: BSE

Please find attached herewith intimation about increase in investment to be made for setting up of manufacturing facility of the Company in Ujjain, Madhya Pradesh.

02 Apr, 2026 | 01:04pm • Source: BSE

Please Find Attached herewith Intimation for Incorporation of Wholly Owned Subsidiary of the Company as a ''Scientific Office''.

30 Mar, 2026 | 05:44pm • Source: BSE

This is to inform you that Mr. Samsher Kumar Deo has been appointed as Senior Management Position in the Company effective from 27th March,2026

27 Mar, 2026 | 06:16pm • Source: BSE

Please find attached herewith Intimation regarding Closure of Trading Window.

27 Mar, 2026 | 11:30am • Source: BSE

Please find attached herewith Press release on Alkem launchesSemaglutide injection in India, with weekly therapy starting at INR 450/-

21 Mar, 2026 | 12:27pm • Source: BSE

Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 26th March,2026.

20 Mar, 2026 | 05:31pm • Source: BSE

Please find attached herewith intimation regarding allotment of land for setting up of a greenfield formulations manufacturing facility of the Company in Ujjain, Madhya Pradesh.

18 Mar, 2026 | 07:52pm • Source: BSE

Please find attached herewith update on Acquisition.

06 Mar, 2026 | 03:41pm • Source: BSE

Please find attached herewith Investor meet on Alkem MedTech''s strategic way forward- video Recording.

20 Feb, 2026 | 06:34pm • Source: BSE

Please find attached herewith updated Investor meet Presentation on Alkem MedTech ''s strategic way forward.

18 Feb, 2026 | 12:58pm • Source: BSE

Enclosed please find herewith investor meet presentation on Alkem MedTech''s strategic way forward

16 Feb, 2026 | 07:38pm • Source: BSE

Please find attached herewith Q3 FY26- Earnings Call Transcript.

16 Feb, 2026 | 05:22pm • Source: BSE

Enclosed please find updated disclosure with regards to closure of USFDA inspection at the manufacturing facility of Enzene Biosciences Limited, a subsidiary of the Company...

16 Feb, 2026 | 03:01pm • Source: BSE

Please find enclosed herewith Press Release.

13 Feb, 2026 | 02:36pm • Source: BSE

Please find enclosed herewith the updated details of the Analyst / Institutional Investor meetings.

13 Feb, 2026 | 02:18pm • Source: BSE

Pl find enclosed press release and analyst presentation on Q3 & 9MFY26 earnings and business updates of the Company.

13 Feb, 2026 | 02:07pm • Source: BSE

The Financial Results of the Company for the quarter and nine months ended 31st December, 2025 having been communicated to the Stock Exchanges today i.e....

13 Feb, 2026 | 02:07pm • Source: BSE

This is to inform you that M/s, Alkem Medtech Pvt Ltd , a wholly owned subsidiary of the Company in India has offered to acquire...

13 Feb, 2026 | 02:02pm • Source: BSE